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Introduction: Data specific to late-life bipolar disorder (BD) are limited. Current research is 
sparse and present guidelines are not adapted to this group of patients.
Objectives: We present a literature review on clinical characteristics, comorbidities, and cog-
nitive impairment in patients with late-life BD. This review discusses common comorbidities 
that affect BD elders and how aging might affect cognition and treatment.
Methods: Eligible studies were identified in MedLine by the Medical Subject Headings terms 
“bipolar disorder” and “aged”. We only included original research reports published in English 
between 2012 and 2015.
Results: From 414 articles extracted, 16 studies were included in the review. Cardiovascular 
and respiratory conditions, type II diabetes, and endocrinological abnormalities were observed 
as highly prevalent. BD is associated with a high suicide risk. Bipolar elderly had an increased 
risk of dementia and performed worse on cognitive screening tests compared to age-matched 
controls across different levels of cognition. Despite high rates of medical comorbidity among 
bipolar elderly, a systematic under-recognition and undertreatment of cardiovascular disease 
have been suggested.
Conclusion: There was a high burden of physical comorbidities and cognitive impairment in 
late-life BD. Bipolar elderly might be under-recorded and undertreated in primary medical care, 
indicating that this group needs an adapted clinical assessment and specific clinical guidelines 
need to be established.
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Introduction
Bipolar disorder (BD) is a major affective disorder marked by recurrent/cyclical episodes 
of mania/hypomania and depression as described in the Diagnostic and Statistical 
Manual of Mental Disorders, 5th edition.1 The subtypes of BD include bipolar disorder I 
(BD-I) and bipolar disorder II (BD-II). Patients with BD-I experience manic episodes 
and nearly always experience major depressive and hypomanic episodes whereas BD-II 
is marked by at least one hypomanic episode, at least one major depressive episode, 
and the absence of manic episodes. To satisfy a clinical diagnosis of BD, the abnormal 
mood episodes should have a detrimental effect on the social and occupational function-
ing of the individual. Late-life BD or geriatric BD usually refers to patients older than 
60 years with BD. However, some authorities use an age cut-off of 50, 55, or 65 years. 
Late-life BD includes both patients diagnosed in their younger years (early-onset BD) 
and in late-life, often called late-onset BD. Due to no validated age-at-onset threshold, 
this definition remains arbitrary.2 One out of four bipolar patients is reported to be 
older than 60 years.3 A systematic review of the prevalence of BD in population-based 
studies revealed heterogeneous findings concerning the prevalence of BD, ranging from 
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0.1% to 7.5%.4 Community surveys in 14 countries found that 
the lifetime prevalence of BD was 2.8%,5 while another set 
of community surveys in eleven countries found a consider-
ably lower lifetime prevalence of BD, with rates of BD-I and 
BD-II reported to be 0.6% and 0.4%, respectively.6 In both 
sexes, the pattern of bipolar diagnoses has been reported to 
increase similarly over the years until middle age where it 
was observed to reach a plateau.7 The considerable variety 
of prevalence rates in BD may be related to the consideration 
of subthreshold criteria upon diagnosis, differences in study 
design, and psychiatric assessment. The annual incident rate 
has been reported to be 30 per 100,000 capita.7 The mean 
standardized mortality ratio for BD has been reported to be 
2.00 with a reduced life expectancy of 9 years among bipolar 
patients.7 The relative risk of all-cause mortality was reported 
to be 2.9 in the age group 65–75 years and highest among 
adults under 45 years (8.95), suggesting that the younger 
population with BD have a specially reduced life expectancy 
compared to the general population.7 An elevated leukocyte 
count often seen in acute affective episode has previously been 
suggested to increase the risk of early natural death from all 
causes in bipolar patients, independent of smoking and other 
cardiovascular risk factors.8
Due to physiological age-related changes, different phar-
macodynamics and kinetics, cognitive impairment, medical 
comorbidity and concomitant medication, long-term treat-
ment with mood stabilizers and their potential negative effect, 
older patients may have different clinical characteristics and 
treatment response than the younger bipolar population.9,10 
Late-life BD has been associated with multiple medical 
comorbidities, and the dominating conditions observed are 
type II diabetes, respiratory and cardiovascular conditions, 
and other endocrine abnormalities.10 It has been suggested 
that medical comorbidity accounts for 40%–70% of personal 
and societal costs of BD.11 Yet, it is not clear whether medical 
disorders among individuals with BD are truly comorbid 
disorders, or a consequence of treatment, or a combination 
of both.12 Lifestyle characteristics such as smoking, diet, 
substance abuse, and metabolic abnormalities related to 
psychotropic drug use contribute to medical complica-
tion and poor prognosis.13 Psychiatric comorbidities have 
previously been reported to be less prevalent than physical 
comorbidities, and the prevalence has appeared to be lower 
in elderly bipolar patients compared to the younger BD 
population, with anxiety and substance abuse disorders being 
the most common concurrent psychiatric illnesses.10 There 
are however some limitations to be considered regarding 
this literature, as no prospective studies have evaluated this 
topic and most studies have been small, retrospective, and 
conducted only on hospitalized patients.10
There seems to be an increase in the amount of published 
research on this topic over the past decade.9 Emerging 
research suggests that BD is not solely an illness of mood 
but that it affects multiple domains impacting overall 
functioning, considering it to be a multisystem condition 
in which medical comorbidity, cognitive impairment, and 
early mortality may have underlying common mechanistic 
elements. To our knowledge, all of the reviews regarding this 
topic consider there is a lack of adapted assessment for this 
group of patients, as their treatment is based on guidelines 
drawn up for younger patients with BD. The aim of the study 
was to identify specific clinical characteristics in individuals 
older than 60 years with BD and to gain more knowledge 
of how aging in these individuals might affect cognitive 
function and treatment.
Methods
PubMed/MedLine was searched for studies about elderly 
(.60 years) patients with BD and their characteristics. 
Selected articles were those with Medical Subject Headings 
term “Bipolar Disorder”, restricted to Medical Subject 
Headings Major Topic, and “aged”. The search was limited 
to studies published in the period January 2012 till January 
2015 in order to obtain the most recent scientific articles. The 
database was searched for original research reports published 
in English from the period November 2014 to January 2015. 
Titles and abstracts from the obtained articles were reviewed 
and all retrieved papers were screened to meet the following 
inclusion criteria:
•	 Studies including patients aged 60 or older or studies 
with participants of any age, only if separate data were 
reported for the patients aged 60 years and older.
•	 Minimum sample size of N=30, as small samples 
may reduce the likelihood that findings reflect a true 
effect.14
•	 A clear definition of BD with diagnostic criteria of 
Diagnostic and Statistical Manual of Mental Disorders-IV 
and -V, and ICD-9 and -10.
Search results
The data search by keywords yielded 414 potentially eligible 
articles. A total of 398 articles were excluded, resulting 
in 16 studies meeting the inclusion criteria. Reasons for 
exclusion were no data specific to patients above 60 years. 
The characteristics of the included studies are listed 
in Table 1. We identified six articles that reported medical 
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Table 1 An overview of the characteristics of the included studies
Authors Design Sample Measurements of 
outcome
Objectives Results
Aprahamian 
et al21
Cross-
sectional
N=86 patients 
with BD
(mean age: 69.2)
MMSe,
vFT, and CDT
To investigate the 
performance on 
cognitive screening 
tests in a sample of 
older adults with BD, 
as compared to non-
BD subjects
Nondemented patients with BD 
had a slightly worse global cognitive 
performance as compared with 
healthy controls and patients 
with cognitive impairment but no 
dementia.
Patients with BD performed worse 
on the vFT, both in the normal 
cognition range and in the dementia 
range.
Birgenheir 
et al17
Cross-
sectional
N=12,857 
patients with BD
$65 years
Primary dependent 
variables were seven 
specific pain conditions: 
arthritis, back pain, 
chronic noncancer pain, 
migraine headache, 
tension, and other 
headache, psychogenic and 
neuropathic
To assess the rates of 
chronic, noncancer 
pain conditions in 
patients with BD 
within the veterans 
Health Administration 
System
Noncancer pain conditions occur 
in elevated rates among patients 
with BD.
After adjusting for other 
demographic and patient 
factors, patients with BD had 
significantly higher odds of having 
any pain condition (OR 1.83) 
as well as every specific pain 
condition (aORs ranging from 
1.50 to 6.24).
Ciulla et al19 Cross-
sectional
N=32 patients 
with BD 
$60 years
Prevalence of ideation, 
attempts, and suicide risk 
measured by MiNiplus
To examine prevalence 
and level of suicide risk 
and its associations 
with sociodemographic 
factors and mood 
disorders
BD was associated with a high 
suicide risk. The increased suicide 
risk was reported for those with 
and without a current mood 
episode.
Clements 
et al20
Cross-
sectional
N=156 patients 
with BD 
$65 years
Suicide database NCi To describe the 
frequency, trends 
over time, and 
characteristics of those 
with BD who died by 
suicide in england
Factors such as alcohol 
dependence/misuse, personality 
disorder, depressive illness, and 
current/recent in-patient admission 
seemed to characterize a high-risk 
group.
Gildengers 
et al25
Cross-
sectional study
N=43 patients 
with BD 
$65 years 
(mean age: 74.0)
21 well-established 
and validated individual 
tests measuring multiple 
cognitive domains
To examine the overall 
patterns of cognitive 
function in patients 
with BD and MDD
Both subjects with BD and 
MDD were impaired across all 
cognitive domains compared to 
controls, most prominently in 
information processing speed and 
executive function. Despite the 
protective effects of having higher 
education and lower vascular 
burden, BD subjects were more 
impaired across all cognitive 
domains compared with MDD 
subjects.
Goldstein 
et al16
Cohort study N=64 patients 
with BD 
$65 years
Obesity was defined as 
having a BMi of $30 kg/m2. 
Respondents were asked 
about the presence of 
eleven medical conditions. 
Short Form 12 version 2, a 
measure of health-related 
quality of life in large 
populations, was used
To examine if obesity 
is associated with an 
increased medical and 
psychiatric burden 
in BD
Obesity independently predicts the 
accumulation of medical conditions 
among adults with BD.
Obese subjects with BD remained 
significantly more likely to report 
any new-onset medical condition 
(OR 2.32), new-onset hypertension 
(OR 1.81), arthritis (OR 1.64), 
physician-diagnosed diabetes 
(OR 6.98), and hyperlipidemia 
(OR 2.32).
(Continued)
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Table 1 (Continued)
Authors Design Sample Measurements of 
outcome
Objectives Results
Kodesh 
et al7
Historical 
cohort study
N=1,521
patients with BD 
$65 years
Database containing 
demographic information, 
medical diagnoses, 
laboratory results, 
medications, treatment 
documentation, and 
information regarding 
medical encounters. The 
database forms the basis 
for merging separate 
registers of patients with 
different chronic diseases 
(CvD, DM, hypertension, 
and cancer)
To investigate the 
epidemiology of 
schizophrenia and 
bipolar affective 
disorder among 
adults, and to assess 
their comorbidity and 
mortality compared to 
the general population
The crude prevalence rate of BD 
was 3 per 1,000 capita. The annual 
incidence rate of BD was 30 per 
100,000 capita. Compared to the 
general population, BD patients had 
a 9-year shorter life expectancy.
They were also more likely to 
be diagnosed with DM (OR 1.6). 
Results showed that both bipolar 
individuals had a slightly higher 
age-adjusted risk of having cancer, 
diabetes, and hypertension 
compared to the general 
population.
Meesters  
et al26
Cross-
sectional
N=74, patients 
with BD type i 
(mean age: 70)
Several tests spanning 
four cognitive domains; 
attention/working 
memory, verbal memory, 
executive function, and 
verbal fluency
To investigate 
differences in cognitive 
impairment between 
schizophrenia and BD
Patients with schizophrenia and 
BD-i were impaired compared to 
healthy controls, with mostly large 
effect sizes for verbal memory and 
verbal fluency, but with smaller 
effect sizes for the domain of 
attention/working memory.
van Melick 
et al28
Retrospective 
study
N=288 patients 
with BD and 
$60 years
vGR, TiTR, TbTR, TaTR, 
and annual number of 
measurements were 
considered a proxy for 
instability
To investigate age as a 
determinant of serum 
lithium concentration 
instability during 
both the titration and 
maintenance phase of 
lithium treatment
Age was not a determinant of 
serum lithium concentration 
instability. vGR and TiTR, TaTR, 
and TbTR did not differ significantly 
between the reference group and 
the two oldest age groups (60–69) 
and ($70). The annual number 
of lithium serum concentration 
measurements was higher in 
the oldest age groups, and this 
difference was significant (P,0.05).
Montes 
et al2
Cross-
sectional
N=69, patients 
with BD 
$65 years
Sociodemographic 
and treatment 
(pharmacological and 
nonpharmacological) 
characteristics. Measures 
of severity and disability
To examine 
demographic, clinical, 
and treatment 
correlates of BD-i vs 
BD-ii and patients with 
early onset versus late 
onset of the illness
Geriatric BD has similar clinical 
characteristics with those of younger 
ages, and these do not seem to 
greatly differ with BD subtype or 
age of onset. The patients were 
receiving a mean of three different 
psychotropic medications. The 
prevalence of lifetime psychiatric 
comorbidity (18.8%) was significantly 
lower than the prevalence of 
physical comorbidity (81.2%). 
The most prevalent physical 
comorbidities were arterial 
hypertension (37.7%), DM (24.6%), 
and hypothyroidism (13%).
Rybakowski 
et al27
Cross-
sectional
N=120 patients 
with BD, 90 
of them who 
were exposed 
to lithium (mean 
age: 60±10)
Measures of kidney 
functions; urine examina-
tion with specific gravity 
evaluation, serum creatine 
concentration, eGFR 
evaluation, and two markers 
of kidney injury: serum 
concentration of neutrophil 
NGAL and urinary 
concentration of β2-MG
To compare the novel 
markers of kidney 
injury between a group 
of long-term lithium-
treated bipolar patients 
and age-matched 
bipolar patients not 
exposed to lithium
Lithium treatment causes an 
impairment of kidney function 
reflected also by abnormal levels 
of novel markers of kidney injury. 
Urinary β2-MG seemed to be a 
better predictor than serum NGAL 
in lithium-treated patients because 
it showed multiple clinical and 
biochemical correlations, especially 
in men.
(Continued)
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Table 1 (Continued)
Authors Design Sample Measurements of 
outcome
Objectives Results
Schouws  
et al23
Cohort study N=65 
patients with BD 
.60 (mean age: 
68.4)
MMSe was used to provide 
an overall assessment 
of cognitive function. 
Several neuropsychological 
tests grouped into four 
cognitive domains were 
used: attention, learning 
and memory, executive 
functioning, and verbal 
fluency
To investigate 
neurocognitive 
performance in
BD over a period of 
2 years
At baseline and at follow-up, 
patients with BD performed worse 
on all neurocognitive measures 
compared to the healthy elderly 
group. However, they did not have 
greater cognitive decline compared 
to the healthy controls.
Schouws  
et al24
Cross-
sectional
N=101 patients 
with BD 
.60 years 
(mean age: 67.8)
MMSe was used to 
provide an overall 
assessment of cognitive 
function. Self-reported 
cognitive problems 
were assessed through 
“The Cognitive Failures 
Questionnaire”. All 
subjects completed several 
neuropsychological tests 
grouped into five cognitive 
domains: attention, 
learning and memory, 
visuoconstructional ability, 
executive functioning and 
verbal fluency
To determine 
whether subjective 
cognitive complaints 
were associated 
with objective 
neuropsychologic 
performance and 
to consider the 
role of frontal lobe 
dysfunction in the 
awareness of cognitive 
impairment
elderly bipolar patients had 
no more subjective cognitive 
complaints than comparison 
subjects, whereas they showed 
less cognitive functioning in several 
domains. Having few subjective 
cognitive complaints was associated 
with poorer attentional and 
executive functioning.
More than 40% of elderly bipolar 
patients who were euthymic had 
considerable subjective cognitive 
complaints.
Sheeran  
et al18
Cross-
sectional
N=50 patients 
with BD 
$60 years
Cognitive status was 
assessed via the MMSe and 
executive functioning was 
assessed via the initiation– 
Perseveration subscale of 
the DRS
To conduct a 
descriptive analysis of 
geriatric and younger 
adult residents 
with BD or mania 
in nonclinical adult 
congregate facilities in 
the greater New York 
City region
Comparing the two age groups, the 
elderly sample had lower overall 
cognitive status and executive 
functioning, and were using a larger 
number of medication classes than 
the younger group.
Smith et al15 Cross-
sectional
N=702 patients 
with BD 
$65 years
Data on the presence of 
32 of the most common 
chronic physical health 
conditions
To assess physical 
comorbidities in BD 
within primary care 
and prescription 
of cardiovascular 
medications
Prevalence was higher for bipolar 
versus non-bipolar for viral hepatitis 
(OR 5.69), constipation (OR 3.37), 
and Parkinson’s disease (OR 3.05). 
Bipolar patients with coronary 
heart disease and bipolar patients 
with hypertension were more 
likely to be current smokers than 
controls (OR 1.55, OR 1.87), less 
likely to be on a statin (OR 0.69, 
OR 0.82), more likely not to be 
on a antihypertensive (OR 2.08 
OR 1.70) and less likely to be on 
two or more antihypertensive 
medications (OR 0.46, OR 0.53).
Compared to controls, individuals 
with BD were significantly less 
likely to have no recorded physical 
conditions, and significantly 
more likely to have one or more 
physical conditions. All P-values 
were ,0.002.
(Continued)
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Table 1 (Continued)
Authors Design Sample Measurements of 
outcome
Objectives Results
wu et al22 Cross-
sectional
N=263 patients 
with BD (mean 
age: 74.1±8.6)
A conditional logistic 
regression model was 
performed using data from 
a nationwide dataset
To investigate whether 
patients with BD were 
at an increased risk for 
developing dementia
BD was significantly associated with 
an increased risk of subsequent 
dementia (aOR 4.32). A significantly 
increased risk was observed in 
subjects diagnosed with dementia 
before the age of 65 years 
(aOR 3.77).
Abbreviations: aOR, adjusted odds ratio; BD, bipolar disorder; BMi, body mass index; CDT, Clock Drawing Test; CvD, cardiovascular disease; DM, diabetes mellitus; 
DRS, Dementia Rating Scale; eGFR, estimated glomerular filtration rate; MDD, major depressive disorder; MINIplus, Mini International Neuropsychiatric Interview plus; 
MMSE, Mini Mental State Examination; NCI, National Confidential Inquiry into Suicide and Homicide by People with Mental Illness; NGAL, plasma neutrophil gelatinase-
associated lipocalin; OR, odds ratio; TaTR, percentage of treatment time that serum lithium concentrations were above the therapeutic range; TbTR, percentage of treatment 
time that serum lithium concentrations were below the therapeutic range; TiTR, percentage of treatment time that serum lithium concentrations were in the therapeutic 
range; VFT, verbal fluency test; VGR, Variance Growth Rate; β2-MG, beta-2 microglobulin.
comorbidity,2,7,15–18 two on suicide,19,20 six on cognitive 
impairment/dementia,21–26 and two on aspects related to 
pharmacological therapy in BD.27,28
The additional burden in the elderly 
with BD
Comorbidity and impairment in the older 
BD population
Elderly bipolar patients were more likely to be diagnosed 
with diabetes mellitus,2 cancer,7 thyroid disorders,2,15 and 
hypertension,2,7 compared to age-matched controls. One of 
the studies comparing comorbidities in bipolar versus non-
bipolar subjects found a high prevalence of viral hepatitis 
and Parkinson’s disease among older bipolar patients.15 
A recent study reported that most of the elderly bipolar 
patients did not present psychiatric comorbidities, and those 
who did were mainly patients with early-onset BD. However, 
the majority of the patients (81.2%) had various physical 
comorbidities.2 A recent cross-sectional analysis found that 
elderly individuals with BD were significantly less likely to 
have no recorded physical conditions and significantly more 
likely to have one (odds ratio [OR] 1.27), two (OR 1.45), 
and three or more (OR 1.44) physical conditions compared 
to age-matched controls.15 The same study also reported 
that individuals with BD and coronary heart disease or 
hypertension were less likely to have a primary-care record 
and experienced much less intensive prescribing for these 
conditions and were treated less intensively compared to 
non-bipolar subjects. Another physical health problem 
observed to be highly prevalent was obesity.16 Findings from 
a longitudinal study examining the impact of obesity on 
comorbidity in BD showed that obese subjects were observed 
to be significantly more likely to report any new-onset medi-
cal condition (OR 2.32), new-onset hypertension, arthritis, 
diabetes, and hyperlipidemia.17 There are indications that 
obesity independently predicts the accumulation of medical 
conditions among adults with BD. Results from a recent 
cross-sectional study showed that BD was independently 
associated with an increased risk of having a diagnosis of 
chronic pain conditions.17 This study investigated the rates 
of seven chronic, noncancer pain conditions in veterans with 
BD, finding elevated rates of pain in these patients compared 
to controls. Patients with BD had significantly higher odds 
of having any pain condition (OR 1.83), as well as specific 
pain condition (adjusted odds ratios [aOR] ranging from 1.50 
to 6.24). Elevated rates of chronic pain conditions were also 
reported by another recent cross-sectional study.15
BD is associated with an elevated risk of suicide and 
suicide mortality in BD has been estimated to be approxi-
mately nine times that of the general population.10 Elevated 
levels of suicide incidents in elderly persons with BD have 
also been documented by other studies, especially in those 
presenting a current mood episode.19 Mixed and depressive 
episodes of BD as well as major depression were found to 
be the most frequent diagnoses in elderly individuals com-
mitting suicide. The same study suggested that bipolar sub-
jects with depressive episodes might have a greater risk of 
committing suicide than subjects with unipolar depression. 
Another study observed a considerable lower rate of suicides 
in the oldest group of patients compared to the middle age 
groups (25–64-year age groups) in which the highest rates 
of suicides were reported. The majority of suicides in the 
sample of bipolar patients took place at least 5 years after 
diagnosis.20 A possible high-risk group of bipolar patients 
with alcohol dependence, concomitant personality disorder, 
depression, and current or recent in-patient admission was 
also identified.20
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Dementia and cognitive impairment in later life are 
common features of BD. Elderly people with BD have been 
reported to have an increased risk of stroke, dementia, and 
other cognitive impairments.9 Compared to non-BD subjects, 
euthymic older adults with BD have been found to perform 
worse on cognitive tests such as the Clock Drawing Test 
and the verbal fluency test, but not on the Mini Mental State 
Examination.21 Findings from a recent population-based 
study of older patients with BD suggested a positive associa-
tion between the presence of a lifetime history of BD and 
an increased risk of developing dementia (aOR 4.07), even 
after controlling for pertinent risk factors.22 These subjects 
tended to develop dementia already in middle age (aOR 
3.77). A recent longitudinal study investigated the neurocog-
nitive performance in the elderly with BD.23 At baseline 
and follow-up, the bipolar patients performed worse on all 
neurocognitive measures compared to the healthy elderly 
group, although the cognitive decline during this period was 
similar in both groups. The association between subjective 
complaints of cognition and objective neuro psychological 
performance has also been investigated. The results provided 
evidence for a clear association between few subjective 
complaints and poorer attentional and executive functioning 
in euthymic elderly bipolar patients.24 It is not clear whether 
BD and major depressive disorder (MDD) have similar or 
different cognitive profiles and levels of impairment in 
older age. Cognition in aged euthymic bipolar patients was 
compared with older adults with MDD by using multiple 
tests measuring different cognitive domains.25 The results 
showed that subjects with BD and MDD were impaired 
across all cognitive domains compared with controls, and 
this was remarkably so concerning information processing 
speed and executive function. Bipolar patients did worse 
than patients with MDD across all cognitive domains, despite 
protective effects of having a higher education and lower 
vascular burden. Cognitive abilities of older bipolar patients 
(BD-I) in euthymic state have also been compared with 
patients with schizophrenia in the same age range.26 Strik-
ingly limited differences in cognitive performance between 
the community-living patients with schizophrenia and the 
bipolar patients were found. However, both groups were 
impaired compared to controls in terms of executive func-
tions. In a descriptive study comparing a group of geriatric 
bipolar patients with a sample of younger bipolar patients, 
a remarkably significant cognitive impairment was found 
across age groups. The older patients were distinguished 
from the younger by having a lower overall cognitive and 
executive functioning.27
Pharmacological therapy
Alterations in pharmacokinetics and dynamics, increasing 
comorbidity, drug interactions, and the subsequent poly-
pharmacy combined with functional and cognitive limitations 
related to aging condition the response to mood stabilizers, 
which is necessary to consider when prescribing medication. 
Previous evidence suggests that pharmacological treatment 
of BD may reduce not only suicide risk but also premature 
mortality from natural causes, such as respiratory and cir-
culatory diseases.8 A recent study observed that most of the 
sample of elderly outpatients received surprisingly only 
pharmacological therapy rather than additional psychosocial 
interventions for BD,2 even though there is evidence that 
these interventions are effective, especially in early stages 
of the disease.29 An average of three different psychotropic 
medications were prescribed to the elderly patients.2 A similar 
need of polytherapy has previously been reported in late-life 
BD.30 As expected, antidepressants were more frequently 
prescribed to patients with BD-II than to patients with BD-I 
and twice as much to patients with an early-onset BD than 
to patients with late-onset BD.
Lithium still remains a pharmacological cornerstone 
for the prevention of manic and depressive recurrences in 
BD.27 It has been previously suggested that lithium may 
also have neuroprotective abilities and may reduce the risk 
of developing dementia.31 In a recent longitudinal study, 
lithium treatment was not associated with cognitive decline.23 
Considering the narrow therapeutic window of lithium and 
the well-known harmful adverse effects of chronic lithium 
intoxication, lithium concentration monitoring is considered 
to be essential. Pharmacological variability, comorbidities, 
and polypharmacy related to the aged could also result in 
instability of serum lithium concentrations. For instance, a 
variety of antihypertensives (thiazide diuretics, angiotensin-
converting-enzyme inhibitors) and nonsteroidal anti-inflam-
matory agents, which are common medications in elderly 
patients, can increase lithium concentrations.32 However, a 
retrospective study which compared serum lithium concen-
trations of bipolar patients in different age groups concluded 
that age does not seem to be a determinant of serum lithium 
concentration instability as they found no significant differ-
ence between the age groups.28 In the majority of patients on 
long-term lithium therapy, a decrease in urinary concentra-
tion ability is observed and chronic interstitial nephropathy 
may develop. A study assessing the long-term effect of 
lithium on kidney function compared older patients on long-
term lithium therapy (with a mean of 16 years of treatment) 
with age-matched patients never exposed to lithium.27 They 
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found that lithium treatment caused an impairment of kidney 
function reflected also by abnormal levels of novel markers of 
kidney injury such as plasma neutrophil gelatinase-associated 
lipocalin and urinary beta-2 microglobulin, the latter prob-
ably being a better predictor because it showed multiple 
clinical and biochemical correlations.
Discussion
The present review examined mainly specific clinical 
characteristics, common comorbid physical conditions, and 
cognitive dysfunction in elderly with BD. The reviewed 
studies suggest that the burden of BD is not limited to higher 
disability and comorbidity, but is also reflected in earlier 
mortality. Comorbid cardiovascular diseases, suicide, and 
cancer have earlier been suggested as the leading causes of 
excess mortality among bipolar patients33 based on findings 
similar to those of the studies included in this review. The 
reviewed studies investigating medical comorbidities found 
many similarities to previous research, providing further 
evidence of high comorbidity in elderly patients with BD. 
Cardiovascular and respiratory conditions, type II diabetes, 
and endocrinological abnormalities have previously been 
reported as the most frequent comorbidities in bipolar 
elderly.10 In addition, Parkinson’s disease and viral hepatitis 
were found to be highly prevalent.15 Although cardiovascular 
diseases were not particularly prevalent in the reviewed stud-
ies, several comorbidities well known as risk factors to car-
diovascular disease, such as hypertension, diabetes, obesity, 
and alcohol abuse, were reported as highly prevalent among 
bipolar elderly compared to the elderly in general. These 
results underscore the importance of contemplating these risk 
factors when assessing and treating BD in elderly patients. 
Evidence for a systematic under-recognition and undertreat-
ment of cardiovascular illnesses in primary medical care was 
also found,15 which has been mentioned previously.34 There 
are several possible reasons for this association. Mood epi-
sodes and/or low awareness of cardiovascular risk factors and 
associated symptoms could have resulted in lower attendance 
rate to the general practitioner. Additionally, individuals with 
BD frequently experience social isolation and lower levels of 
education, which are also associated with higher unmet need 
for treatment. We cannot rule out that the cardiovascular risk 
factors in these subjects may be overlooked by the general 
practitioners while engaging their attention toward their 
mental illness. An average of three to four medical comorbid 
conditions have previously been reported in elderly bipolar 
patients;10 similar findings are reported in the reviewed 
studies. A strong association between obesity and a high 
medical burden in BD was also observed16 suggesting that 
overweight is an additional burden in many elderly with BD. 
It is noteworthy to consider that treatment of obesity could 
potentially mitigate the psychiatric and medical burden of 
BD. Also, pain conditions were reported to be highly preva-
lent in bipolar elderly.15,17 This association has previously 
received little attention, despite being related to reduced 
quality of life among those with mental illness. Even though 
such an association may be caused by depressive symptoms, it 
demonstrates another clinical area of need for this population 
that is being overlooked. Chronic pain conditions have also 
been related to an increased suicide risk, an aspect that needs 
to be considered also in the approach of the elderly bipolar 
population.35 The extent to which chronic pain might impact 
mental health recovery remains to be investigated.
The association between cognitive dysfunction and BD 
was corroborated by findings in this review. The pathophysio-
logy behind the relationship between BD and the subsequent 
development of dementia largely remains unclear. Many 
possible mechanisms may underlie cognitive deficits in 
older adults with BD, such as residual mood symptoms, 
structural brain abnormalities, long-term side effects of 
medications, adverse psychosocial conditions, and medical 
comorbidities. Bipolar elderly performed significantly worse 
on some screening tests of cognitive function,21 and a positive 
association between the presence of BD and an increased 
risk of developing dementia was found.22 The elderly, in 
particular, represented a heterogeneous group, suggest-
ing that various causes of cognitive impairment may have 
played a role in its development, emphasizing the need for 
further investigation of the underlying neuropathophysio-
logical and pathological mechanisms that connect BD 
and dementia. One of the studies reviewed compared older 
bipolar subjects with a group of non-BD patients matched 
for distinct degrees of cognitive impairment, providing 
greater evidence to the results.21 However, it is important to 
consider confounding factors that can bias the link between 
cognitive dysfunction and BD, such as educational level, 
a family history of dementia, and socioeconomic status. 
Even though data were statistically significant, the clinical 
meaning of these differences is uncertain. Results showed 
that older adults with BD exhibited worse cognitive function-
ing compared to healthy controls, regardless of comparable 
vascular risk factors.23 This implies that there may be inherent 
factors related to the disease process that results in cognitive 
impairment, and not simply a manifestation of vascular risk 
factors. Even though disease exacerbations are associated 
with increasing cognitive dysfunction, there is increasing 
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evidence of a higher risk of permanent cognitive impair-
ment in bipolar patients. It is important to underline that all 
of the reviewed studies regarding this topic compared only 
bipolar patients in euthymic state with controls. Another 
important finding was the relation between having few sub-
jective complaints about cognition and poor attentional and 
executive functioning suggesting that impaired awareness 
of cognition might be a reflection of cognitive deteriora-
tion. If so, this may influence assessment and treatment of 
these individuals as poor perception of such function may 
compromise communication of symptoms and functional 
deficits. Subjects with BD were observed to have cognitive 
dysfunction comparable to patients with schizophrenia 
and they were also reported to be more impaired across all 
cognitive domains compared with patients with MDD.25,26 
Recommendations to preserve cognitive function target 
known risk factors associated indirectly with cognitive 
decline, such as hypertension, hypercholesterolemia, and 
diabetes mellitus. The relative neglect of the management 
of severe medical comorbidity associated with BD is still a 
significant challenge.
The consensus regarding high suicide risk among elderly 
bipolar patients compared to elderly in general was also 
suggested by the studies included in our review.19 Although, 
the risk was found to be lower among older patients compared 
to middle-aged,20 which is consistent to previous findings.36 
Nevertheless, the committed suicide rates are higher among 
the elderly in comparison with young people,37 an aspect not 
mentioned in the included studies in this review.
Long-term treatment with lithium is often indicated in BD, 
which means extensive monitoring is essential to minimize 
adverse effects. Due to age-related factors, age has been 
suggested as a determinant of serum lithium concentration 
instability, which may be one of several reasons why lower 
daily dosages of lithium have been used in older patients 
with BD.30 Findings in one recent study differed from this 
idea suggesting that age is not an indication to not initiate or 
discontinue lithium therapy.28 As lithium can be associated 
with nephropathy, kidney function should be assessed 
frequently. Novel markers of kidney injury were compared in 
one study, suggesting urinary beta-2 microglobulin, a marker 
of tubular function, to be a better predictor than plasma 
neutrophil gelatinase-associated lipocalin.27 It remains to 
be seen if beta-2 microglobulin can make a better marker of 
kidney function than estimated glomerular filtration rate.
There are limitations to consider in this review. As 
most of the included studies were cross-sectional analyses, 
causal relationship cannot be established. This highlights the 
importance of future longitudinal studies allowing inferences 
to be drawn about important characteristics of this popula-
tion. Due to limited age criteria in our search, sample sizes 
of the included studies varied. Further, some cross-sectional 
studies used data from nationwide datasets with reasonably 
large samples while other study designs were longitudinal 
having smaller samples. However, given the relatively sparse 
number of longitudinal studies in the field the results from 
these studies contribute significantly to the current knowl-
edge. We found that studies of psychiatric comorbidity 
in the reviewed age group were scarce. Few articles were 
identified within our searched timeframe; thus, this topic 
was not emphasized in the review. A global tendency in the 
reviewed articles was a lack of bipolar subtype specificity, 
which means that some of the findings may be more suitable 
for either BD-I or BD-II. This is a major problem in general 
as the prevalence of the two bipolar types is different, with 
BD-I being rather rare compared to BD-II. The majority of 
the studies are either European or North American and hence 
the findings reflect mainly the population in these areas. It 
would be interesting that future investigation on this topic 
would highlight the possible differences among bipolar sub-
type, sex, and ethnicity. There was a lack of recent studies 
published regarding pharmacotherapy and considering its 
essential role in BD treatment, it would be convenient for 
more empirical data concerning psychotropic medications 
in late-life BD.
Conclusion and future perspective
Our review supports what recent studies have suggested: 
there is a high burden of comorbidities in late-life BD and 
cognitive impairment is common. Individuals with the 
disorder have an elevated risk of being affected by several 
comorbid psychiatric and especially somatic disorders, and 
hence clinicians should be especially attentive to physical 
comorbidity and early signs of cognitive decline, which 
may decrease mortality and herald polytherapy and the 
dementia outcome. Bipolar elderly may be under-recorded 
and undertreated in primary medical care, particularly for 
cardiovascular comorbidity, which is one of the leading 
causes of excess mortality in BD; thus, improved recog-
nition of BD and provision of primary medical care may 
effectively reduce mortality and cognitive decline among 
these patients. Integrated treatment focusing simultane-
ously on psychiatric and medical outcomes may offer 
substantial advantages over usual care, which is often 
fragmented. The review of the literature indicates that 
clinical characteristics between the elderly and the younger 
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population differ, suggesting that the clinical assessment 
of each group should be different and adapted. The het-
erogeneity of function and comorbid symptoms in this 
group of elderly bipolar patients clearly shows that it is 
important to highlight the need of an individual approach 
to each patient.
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